Targeting P4HA1 promotes CD8⁺ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity

Area of Science:

• Immunology
• Cancer Biology
• Metabolic Pathways

Background:

• Effective cancer immunotherapy requires robust intratumoral and systemic immune responses, which remain challenging to achieve for many patients.
• CD8+ T cell differentiation and function are critical for anti-tumor immunity but are often impaired within the tumor microenvironment.

Purpose of the Study:

• To identify novel regulators of CD8+ T cell differentiation and function in the context of cancer immunotherapy.
• To investigate the role of prolyl 4-hydroxylase 1 (P4HA1) in T cell exhaustion and its potential as a therapeutic target.

Main Methods:

• Analysis of P4HA1 expression in tumor-draining lymph nodes (TDLNs) and hypoxic tumor microenvironments.
• Investigating the impact of P4HA1 accumulation in mitochondria on the tricarboxylic acid (TCA) cycle and T cell metabolism.
• Evaluating the effects of P4HA1 targeting on CD8+ T cell progenitor expansion and exhaustion in preclinical cancer models.

Main Results:

• P4HA1 is significantly upregulated in TDLNs and hypoxic tumors, correlating with impaired CD8+ T cell differentiation.
• Mitochondrial P4HA1 disrupts the TCA cycle via aberrant α-ketoglutarate and succinate metabolism, leading to T cell exhaustion and suppressed progenitor expansion.
• Targeting P4HA1 enhances both adoptive and endogenous TCF1+ CD8+ T progenitor expansion and mitigates T cell exhaustion systemically.

Conclusions:

• P4HA1 acts as a crucial regulator of CD8+ T cell exhaustion in cancer, orchestrating an immune-escape program.
• Targeting P4HA1 represents a promising T cell-directed strategy for enhancing systemic anti-cancer immunity in solid tumors.